New delivery for gene therapy

The prospect of being able to re-dose a gene therapy has come into the fore with the launch on 4 January of Generation Bio Inc, a company with technology for delivering DNA directly to the liver using lipid nanoparticles rather than a viral vector.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United States